Areas of focus for our research
We are working to take on the challenges of these cancers, so that we can improve outcomes for patients by:
- Better understanding their causes and biology
- Identifying new therapeutic targets and discovering new therapies to tackle them
- Running clinical trials for potential ways to treat them.
Our Chief Executive, Professor Kristian Helin, describes our vital work in this area: “We are working to develop new drugs including those that target especially challenging and novel targets – drugs which we hope will improve the survival rates of cancers that remain hard to treat.”
Tim Morgan was diagnosed with stage 4 bowel cancer in 2015. He underwent operations, several rounds of chemotherapy and immunotherapy and a new targeted gene treatment – but none of the treatments worked for long. He died in November 2019, aged 48.
Tim’s wife Hilary says: “The discoveries being made at the ICR are very exciting, and the advances in research gave us more time to spend making memories together as a family. It is so important that the ICR continue to improve our understanding of bowel cancer, so future patients have a better chance of being cured or living well with their cancer.”
To find out more about cancers of unmet need and to support our research, please contact Hannah Joyce, Deputy Director of Philanthropy.